Impax Laboratories (IPXL) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Financial Fact:
Cost of revenues: 136.87M
Today's EPS Names:
ITG, MTEX, NSYS, More
Financial Fact:
Cost of revenues: 136.87M
Today's EPS Names:
ITG, MTEX, NSYS, More
Join SI Premium – FREE
Impax Laboratories (NASDAQ: IPXL) reported Q3 EPS of $0.40, $0.01 better than the analyst estimate of $0.39. Revenue for the quarter came in at $221.1 million versus the consensus estimate of $214.69 million.
For earnings history and earnings-related data on Impax Laboratories (IPXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Capstone Energy+, Inc. (CEPL) Reports Q2 Loss of $0.03
- Southland Holdings (SLND) Misses Q2 EPS by 122c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
